Loading
Latest filing published 12 Mar 2024 for Lipocine Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Krista Fogarty in Lipocine Inc., where the filings describe the role as senior executive. Over a trading history stretching from 17 May 2022 to 8 March 2024, the count stands at 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €10k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.
Most recently, on 12 March 2024, the filings show a share grant in Lipocine Inc. The last insider purchase was made public on 17 May 2022, 1,615 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations